People news: Lilly, J&J and Merck

Share this article:
Lilly named Lilly USA president Dave Ricks SVP and president of Lilly Bio-Medicines, in which role he'll succeed Bryce Carmine, who is retiring. Ricks assumes responsibility for the US, Japan and Europe operations of Bio-Medicines, which encompasses the therapeutic areas of neuroscience, cardiovascular, autoimmunity, musculoskeletal and urology. Replacing him as Lilly USA president is Alex Azar, who was previously VP US managed healthcare services and Puerto Rico.

J&J marketer Brian Perkins is leaving the company, Advertising Age reported. Perkins, who is VP corporate affairs at J&J, is the top marketing exec at the company, where he's spent the past 31 years, and will leave in February, the magazine reported.

Merck's Richard Clark, who brought the company back from the brink in the wake of the Vioxx debacle, stepped down as chairman. Clark was president and CEO from 2005 to 2010, when he turned over the reins to Ken Frazier, who now assumes the responsibility of chairman as well. During his tenure, Clark restored luster to a brand that was badly damaged when he took over.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in People Moves

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in People Moves

Monday Moves: October 20

Promotions and hires for agencies and manufacturers

Monday Moves: September 29

Promotions and hires for agencies and manufacturers

Monday Moves—July 21, 2014

Hires and promotions for Manufacturers, Agencies and Media